These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 9041940)

  • 1. Effects of tenidap on the progression of osteoarthritic lesions in a canine experimental model. Suppression of metalloprotease and interleukin-1 activity.
    Fernandes JC; Caron JP; Martel-Pelletier J; Jovanovic D; Mineau F; Tardif G; Otterness IG; Pelletier JP
    Arthritis Rheum; 1997 Feb; 40(2):284-94. PubMed ID: 9041940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of tenidap on canine experimental osteoarthritis. I. Morphologic and metalloprotease analysis.
    Fernandes JC; Martel-Pelletier J; Otterness IG; Lopez-Anaya A; Mineau F; Tardif G; Pelletier JP
    Arthritis Rheum; 1995 Sep; 38(9):1290-303. PubMed ID: 7575725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The therapeutic effects of tenidap in canine experimental osteoarthritis: relationship with biochemical markers.
    Jovanovic D; Caron JP; Martel-Pelletier J; Fernandes JC; Ricketts T; Pelletier JP
    J Rheumatol; 1997 May; 24(5):916-25. PubMed ID: 9150082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of tenidap on canine experimental osteoarthritis: II. Study of the expression of collagenase-1 and interleukin 1beta by in situ hybridization.
    Fernandes JC; Martel-Pelletier J; Jovanovic D; Tardif G; DiBattista JA; Lascau-Coman V; Otterness IG; Pelletier JP
    J Rheumatol; 1998 May; 25(5):951-8. PubMed ID: 9598897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo dual inhibition of cyclooxygenase and lipoxygenase by ML-3000 reduces the progression of experimental osteoarthritis: suppression of collagenase 1 and interleukin-1beta synthesis.
    Jovanovic DV; Fernandes JC; Martel-Pelletier J; Jolicoeur FC; Reboul P; Laufer S; Tries S; Pelletier JP
    Arthritis Rheum; 2001 Oct; 44(10):2320-30. PubMed ID: 11665972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chondroprotective effect of intraarticular injections of interleukin-1 receptor antagonist in experimental osteoarthritis. Suppression of collagenase-1 expression.
    Caron JP; Fernandes JC; Martel-Pelletier J; Tardif G; Mineau F; Geng C; Pelletier JP
    Arthritis Rheum; 1996 Sep; 39(9):1535-44. PubMed ID: 8814066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced progression of experimental osteoarthritis in vivo by selective inhibition of inducible nitric oxide synthase.
    Pelletier JP; Jovanovic D; Fernandes JC; Manning P; Connor JR; Currie MG; Di Battista JA; Martel-Pelletier J
    Arthritis Rheum; 1998 Jul; 41(7):1275-86. PubMed ID: 9663486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The in vivo effects of intraarticular corticosteroid injections on cartilage lesions, stromelysin, interleukin-1, and oncogene protein synthesis in experimental osteoarthritis.
    Pelletier JP; DiBattista JA; Raynauld JP; Wilhelm S; Martel-Pelletier J
    Lab Invest; 1995 May; 72(5):578-86. PubMed ID: 7745952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Licofelone reduces progression of structural changes in a canine model of osteoarthritis under curative conditions: effect on protease expression and activity.
    Moreau M; Boileau C; Martel-Pelletier J; Brunet J; Laufer S; Pelletier JP
    J Rheumatol; 2006 Jun; 33(6):1176-83. PubMed ID: 16652435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diacerhein treatment reduces the severity of osteoarthritis in the canine cruciate-deficiency model of osteoarthritis.
    Smith GN; Myers SL; Brandt KD; Mickler EA; Albrecht ME
    Arthritis Rheum; 1999 Mar; 42(3):545-54. PubMed ID: 10088778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tenidap reduces the level of interleukin 1 receptors and collagenase expression in human arthritic synovial fibroblasts.
    Martel-Pelletier J; Mineau F; Tardif G; Fernandes JC; Ranger P; Loose L; Pelletier JP
    J Rheumatol; 1996 Jan; 23(1):24-31. PubMed ID: 8838504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intraarticular injections with methylprednisolone acetate reduce osteoarthritic lesions in parallel with chondrocyte stromelysin synthesis in experimental osteoarthritis.
    Pelletier JP; Mineau F; Raynauld JP; Woessner JF; Gunja-Smith Z; Martel-Pelletier J
    Arthritis Rheum; 1994 Mar; 37(3):414-23. PubMed ID: 8129797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo suppression of early experimental osteoarthritis by interleukin-1 receptor antagonist using gene therapy.
    Pelletier JP; Caron JP; Evans C; Robbins PD; Georgescu HI; Jovanovic D; Fernandes JC; Martel-Pelletier J
    Arthritis Rheum; 1997 Jun; 40(6):1012-9. PubMed ID: 9182910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective inhibition of inducible nitric oxide synthase in experimental osteoarthritis is associated with reduction in tissue levels of catabolic factors.
    Pelletier JP; Lascau-Coman V; Jovanovic D; Fernandes JC; Manning P; Connor JR; Currie MG; Martel-Pelletier J
    J Rheumatol; 1999 Sep; 26(9):2002-14. PubMed ID: 10493683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Collagenase-1 and collagenase-3 synthesis in normal and early experimental osteoarthritic canine cartilage: an immunohistochemical study.
    Fernandes JC; Martel-Pelletier J; Lascau-Coman V; Moldovan F; Jovanovic D; Raynauld JP; Pelletier JP
    J Rheumatol; 1998 Aug; 25(8):1585-94. PubMed ID: 9712105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carprofen simultaneously reduces progression of morphological changes in cartilage and subchondral bone in experimental dog osteoarthritis.
    Pelletier JP; Lajeunesse D; Jovanovic DV; Lascau-Coman V; Jolicoeur FC; Hilal G; Fernandes JC; Martel-Pelletier J
    J Rheumatol; 2000 Dec; 27(12):2893-902. PubMed ID: 11128682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential in vivo expression of collagenase messenger RNA in synovium and cartilage. Quantitative comparison with stromelysin messenger RNA levels in human rheumatoid arthritis and osteoarthritis patients and in two animal models of acute inflammatory arthritis.
    Wolfe GC; MacNaul KL; Buechel FF; McDonnell J; Hoerrner LA; Lark MW; Moore VL; Hutchinson NI
    Arthritis Rheum; 1993 Nov; 36(11):1540-7. PubMed ID: 8240430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of human normal and osteoarthritic chondrocyte interleukin-1 receptor by antirheumatic drugs.
    Pelletier JP; McCollum R; DiBattista J; Loose LD; Cloutier JM; Martel-Pelletier J
    Arthritis Rheum; 1993 Nov; 36(11):1517-27. PubMed ID: 8240429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective inhibition of inducible nitric oxide synthase reduces progression of experimental osteoarthritis in vivo: possible link with the reduction in chondrocyte apoptosis and caspase 3 level.
    Pelletier JP; Jovanovic DV; Lascau-Coman V; Fernandes JC; Manning PT; Connor JR; Currie MG; Martel-Pelletier J
    Arthritis Rheum; 2000 Jun; 43(6):1290-9. PubMed ID: 10857787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral treatment with PD-0200347, an alpha2delta ligand, reduces the development of experimental osteoarthritis by inhibiting metalloproteinases and inducible nitric oxide synthase gene expression and synthesis in cartilage chondrocytes.
    Boileau C; Martel-Pelletier J; Brunet J; Tardif G; Schrier D; Flory C; El-Kattan A; Boily M; Pelletier JP
    Arthritis Rheum; 2005 Feb; 52(2):488-500. PubMed ID: 15693013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.